Crossject SA
PAR:ALCJ

Watchlist Manager
Crossject SA Logo
Crossject SA
PAR:ALCJ
Watchlist
Price: 2.09 EUR 1.7% Market Closed
Market Cap: €108.6m

Operating Margin

0%
Current
No historical data
Comparison unavailable

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
0%
=
€0
/
€0

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
0%
=
€0
/
€0

Peer Comparison

Country Company Market Cap Operating
Margin
FR
Crossject SA
PAR:ALCJ
105.9m EUR
Loading...
JP
Hoya Corp
TSE:7741
8.5T JPY
Loading...
CH
Alcon AG
SIX:ALC
31B CHF
Loading...
US
Medline Inc
NASDAQ:MDLN
36.2B USD
Loading...
DK
Coloplast A/S
CSE:COLO B
121.3B DKK
Loading...
US
Align Technology Inc
NASDAQ:ALGN
12B USD
Loading...
UK
ConvaTec Group PLC
LSE:CTEC
4.8B GBP
Loading...
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
43.8B CNY
Loading...
CA
Bausch + Lomb Corp
NYSE:BLCO
6B USD
Loading...
CH
Ypsomed Holding AG
SIX:YPSN
4.5B CHF
Loading...
KR
HLB Inc
KOSDAQ:028300
7.5T KRW
Loading...

Market Distribution

Not Available
No Country distribution data available for this multiple

Crossject SA
Glance View

Market Cap
108.6m EUR
Industry
Health Care

Crossject SA manufactures and markets needle-free injection system. The company is headquartered in Dijon, Bourgogne-Franche-Comte. The firm specializes in needle-free, pre-filled, single-use injection systems for intradermal, subcutaneous and intramuscular applications for pharmaceutical companies. Is also has a pipeline and three drugs in the preclinical or clinical phase of research. The firm's products, which are based on well-known injectable drugs (chemicals and biologics), are designed to enhance patients' safety, compliance and comfort. Crossject’s first ZENEO SUPERGENERIC product is expected to reach the market in the year 2015. The firm has industrial partnerships with Hirtenberger and Recipharm.

ALCJ Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Back to Top